These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29535625)

  • 1. Treating Cocaine Addiction, Obesity, and Emotional Disorders by Viral Gene Transfer of Butyrylcholinesterase.
    Brimijoin S; Gao Y; Geng L; Chen VP
    Front Pharmacol; 2018; 9():112. PubMed ID: 29535625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological roles for butyrylcholinesterase: A BChE-ghrelin axis.
    Brimijoin S; Chen VP; Pang YP; Geng L; Gao Y
    Chem Biol Interact; 2016 Nov; 259(Pt B):271-275. PubMed ID: 26915976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butyrylcholinesterase: A Multifaceted Pharmacological Target and Tool.
    Ha ZY; Mathew S; Yeong KY
    Curr Protein Pept Sci; 2020; 21(1):99-109. PubMed ID: 31702488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma butyrylcholinesterase regulates ghrelin to control aggression.
    Chen VP; Gao Y; Geng L; Parks RJ; Pang YP; Brimijoin S
    Proc Natl Acad Sci U S A; 2015 Feb; 112(7):2251-6. PubMed ID: 25646463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Delivery of Butyrylcholinesterase by Brain-Wide Viral Gene Transfer to Mice.
    Gao Y; Geng L; Chen VP; Brimijoin S
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28698452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and therapeutic uses of butyrylcholinesterase: Application in detoxification, Alzheimer's disease, and fat metabolism.
    Xing S; Li Q; Xiong B; Chen Y; Feng F; Liu W; Sun H
    Med Res Rev; 2021 Mar; 41(2):858-901. PubMed ID: 33103262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butyrylcholinesterase regulates central ghrelin signaling and has an impact on food intake and glucose homeostasis.
    Chen VP; Gao Y; Geng L; Brimijoin S
    Int J Obes (Lond); 2017 Sep; 41(9):1413-1419. PubMed ID: 28529331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable Impact on Stress-Related Behaviors by Modulating Plasma Butyrylcholinesterase.
    Brimijoin S; Tye S
    Cell Mol Neurobiol; 2018 Jan; 38(1):7-12. PubMed ID: 28712092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butyrylcholinesterase distribution in the mouse gastrointestinal tract: An immunohistochemical study.
    Severi I; Abbatelli S; Perugini J; Di Mercurio E; Senzacqua M; Giordano A
    J Anat; 2023 Feb; 242(2):245-256. PubMed ID: 36004682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
    Duysen EG; Li B; Darvesh S; Lockridge O
    Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling effects of oxyanion hole on the ester hydrolysis catalyzed by human cholinesterases.
    Gao D; Zhan CG
    J Phys Chem B; 2005 Dec; 109(48):23070-6. PubMed ID: 16854005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butyrylcholinesterase gene transfer in obese mice prevents postdieting body weight rebound by suppressing ghrelin signaling.
    Chen VP; Gao Y; Geng L; Brimijoin S
    Proc Natl Acad Sci U S A; 2017 Oct; 114(41):10960-10965. PubMed ID: 28973869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologic and metabolic safety of butyrylcholinesterase gene therapy in mice.
    Murthy V; Gao Y; Geng L; LeBrasseur NK; White TA; Parks RJ; Brimijoin S
    Vaccine; 2014 Jul; 32(33):4155-62. PubMed ID: 24892251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical studies on neurobehavioral and neuromuscular effects of cocaine hydrolase gene therapy in mice.
    Murthy V; Gao Y; Geng L; LeBrasseur N; White T; Brimijoin S
    J Mol Neurosci; 2014 Jul; 53(3):409-16. PubMed ID: 24085526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic characterization of cholinesterases and a therapeutically valuable cocaine hydrolase for their catalytic activities against heroin and its metabolite 6-monoacetylmorphine.
    Kim K; Yao J; Jin Z; Zheng F; Zhan CG
    Chem Biol Interact; 2018 Sep; 293():107-114. PubMed ID: 30080993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine.
    Xue L; Ko MC; Tong M; Yang W; Hou S; Fang L; Liu J; Zheng F; Woods JH; Tai HH; Zhan CG
    Mol Pharmacol; 2011 Feb; 79(2):290-7. PubMed ID: 20971807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved cocaine hydrolase: the A328Y mutant of human butyrylcholinesterase is 4-fold more efficient.
    Xie W; Altamirano CV; Bartels CF; Speirs RJ; Cashman JR; Lockridge O
    Mol Pharmacol; 1999 Jan; 55(1):83-91. PubMed ID: 9882701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged toxic effects after cocaine challenge in butyrylcholinesterase/plasma carboxylesterase double knockout mice: a model for butyrylcholinesterase-deficient humans.
    Duysen EG; Lockridge O
    Drug Metab Dispos; 2011 Aug; 39(8):1321-3. PubMed ID: 21540357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions.
    Minic J; Chatonnet A; Krejci E; Molgó J
    Br J Pharmacol; 2003 Jan; 138(1):177-87. PubMed ID: 12522088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential anti-obesity effects of a long-acting cocaine hydrolase.
    Zheng X; Deng J; Zhang T; Yao J; Zheng F; Zhan CG
    Chem Biol Interact; 2016 Nov; 259(Pt B):99-103. PubMed ID: 27163854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.